Pharmaceutical ETFs news and market signals

Novartis has reported second-quarter earnings and revenue that surpassed analyst expectations, reinforcing the financial health of a key player in the global pharmaceutical industry. This positive performance, coupled with a reaffirmed full-year 2026 outlook, provides a stable signal for investors monitoring healthcare-focused exchange-traded funds.